Sumitomo Dainippon Pharma

URI: https://gptkb.org/entity/Sumitomo_Dainippon_Pharma

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:biotechnology
gptkbp:alternativeName	gptkb:Sumitomo_Pharma gptkb:Sumitomo_Dainippon_Pharma_Co.,_Ltd.
gptkbp:CEO	gptkb:Hiroshi_Nomura
gptkbp:country	gptkb:Japan
gptkbp:founded	2005
gptkbp:headquarters_location	gptkb:Osaka,_Japan
https://www.w3.org/2000/01/rdf-schema#label	Sumitomo Dainippon Pharma
gptkbp:industry	pharmaceuticals
gptkbp:member	gptkb:Sumitomo_Group
gptkbp:mergedInto	gptkb:Dainippon_Pharmaceutical gptkb:Sumitomo_Pharmaceuticals
gptkbp:notableProduct	gptkb:Aptiom gptkb:Latuda gptkb:Lunesta gptkb:Cymbalta
gptkbp:numberOfEmployees	about 7,000
gptkbp:parentCompany	gptkb:Sumitomo_Chemical
gptkbp:products	pharmaceutical drugs
gptkbp:researchInterest	infectious diseases neurology oncology psychiatry
gptkbp:servesArea	worldwide
gptkbp:stockExchange	gptkb:Tokyo_Stock_Exchange
gptkbp:stockSymbol	4506
gptkbp:subsidiary	gptkb:Sumitomo_Pharma_America
gptkbp:website	https://www.ds-pharma.com/
gptkbp:bfsParent	gptkb:Roivant_Sciences
gptkbp:bfsLayer	5